Preparations of Cannabis Sativa (Cannabinoid drugs: e.g. marihuana, hashish, bhang) have been used for analgesia, sedation, attenuation of the nausea and vomiting due to cancer chemotherapy, appetite stimulation, decreasing bronchial constriction, decreasing intraocular pressure in glaucoma, treatment of certain motor or convulsant disorders and for their mood altering properties. The CB1 receptor is a helix-transmembrane spanning, G-protein coupled receptor found in abundance in the brain. The goal of this research is to characterize signal transduction mechanisms of the CB1 cannabinoid receptor.
The specific aims are to test the following hypothesis: The HelixII-asp-Helix VII-asn interaction maintains a conformational constraint on the CB1 receptor that can be modified by Na+, leading to effects on signal transduction that differ with agonist class and G-protein type. The Helix VII-pro distal to the asn can transmit conformational changes important for signal transduction.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
International Research Fellowships (FIC) (F05)
Project #
3F05NS011110-02S1
Application #
6466465
Study Section
Special Emphasis Panel (ZNS1 (99))
Program Officer
Michel, Mary E
Project Start
2000-09-19
Project End
Budget Start
2001-09-19
Budget End
2002-09-18
Support Year
2
Fiscal Year
2001
Total Cost
$49,412
Indirect Cost
Name
North Carolina Central University
Department
Type
Organized Research Units
DUNS #
072026321
City
Durham
State
NC
Country
United States
Zip Code
27707